Tandlægeselskabet Godt Smil Randers ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 5.1% 5.5% 5.3%  
Credit score (0-100)  0 0 42 40 41  
Credit rating  N/A N/A BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 -0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 2,765 4,246 5,348  
EBITDA  0.0 0.0 -472 -503 280  
EBIT  0.0 0.0 -946 -1,158 -410  
Pre-tax profit (PTP)  0.0 0.0 -1,103.5 -1,379.9 -700.2  
Net earnings  0.0 0.0 -860.3 -1,070.7 -540.3  
Pre-tax profit without non-rec. items  0.0 0.0 -1,103 -1,380 -700  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 4,240 4,049 3,383  
Shareholders equity total  0.0 0.0 203 -867 -1,408  
Interest-bearing liabilities  0.0 0.0 2,128 3,757 3,927  
Balance sheet total (assets)  0.0 0.0 5,806 6,033 5,356  

Net Debt  0.0 0.0 1,997 3,670 3,861  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 2,765 4,246 5,348  
Gross profit growth  0.0% 0.0% 0.0% 53.5% 26.0%  
Employees  0 0 6 8 7  
Employee growth %  0.0% 0.0% 0.0% 33.3% -12.5%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 5,806 6,033 5,356  
Balance sheet change%  0.0% 0.0% 0.0% 3.9% -11.2%  
Added value  0.0 0.0 -472.2 -684.3 280.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 3,766 -847 -1,356  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 -1.0 -2.0 -3.0  

Profitability 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% -34.2% -27.3% -7.7%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% -16.1% -17.8% -5.5%  
ROI %  0.0% 0.0% -18.3% -19.7% -6.0%  
ROE %  0.0% 0.0% -422.9% -34.3% -9.5%  

Solidity 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  0.0% 0.0% 3.5% -12.7% -21.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% -422.8% -729.1% 1,377.0%  
Gearing %  0.0% 0.0% 1,046.0% -433.2% -279.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 15.7% 8.6% 8.4%  

Liquidity 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.0 0.3 0.3 0.2  
Current Ratio  0.0 0.0 0.3 0.3 0.3  
Cash and cash equivalent  0.0 0.0 131.4 86.8 66.1  

Capital use efficiency 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 -1,868.4 -3,031.4 -3,194.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 -79 -86 40  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 -79 -63 40  
EBIT / employee  0 0 -158 -145 -59  
Net earnings / employee  0 0 -143 -134 -77